Stay updated on Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Sign up to get notified when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.

Latest updates to the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page
- Check6 days agoChange DetectedThe history page shows a new 2026-03-05 entry adding a Study Status item and a Revision: v3.4.3. The 2025-09-05 entry (Revision: v3.4.2) was removed.SummaryDifference0.5%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page history now includes a new entry: Revision: v3.4.2, and older items—the Notice about government funding lapse and Revision: v3.4.1—were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check41 days agoChange DetectedA site-wide notice about government funding status is added and a new revision tag (v3.4.1) is shown, while the previous revision tag (v3.4.0) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedThe page now includes a glossary toggle and uses color-coded highlights to distinguish additions (green) and deletions (red). The revision note updated from v3.3.4 to v3.4.0 and the 'No FEAR Act data' line was removed.SummaryDifference0.9%

- Check62 days agoChange DetectedA new record-history revision v3.3.4 was added, and revision v3.3.3 was removed.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.3.3 is now shown and the HHS Vulnerability Disclosure link has been removed from the page footer, representing minor UI/navigation updates with no impact on study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.